David Dornan
CIK 1821353 · Chief Scientific Officer · last filed 2026-04-03
David Dornan is a Chief Scientific Officer who has filed 9 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for WHWK, was dated Apr 3, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Chief Scientific Officer | — | $4.16 | — | $0 | 1 | 2026-04-03 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | Chief Scientific Officer | — | $2.05 | — | $0 | 1 | 2025-03-04 |
| Elevation Oncology, Inc. (ELEV) Delisted | CHIEF SCIENTIFIC OFFICER | 5,223 | $0.36 | $1.9K | $0 | 5 | 2025-02-19 |
| BOLT | Chief Scientific Officer | — | $4.56 | — | $0 | 2 | 2022-02-23 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2025-03-04 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | Elevation Oncology, Inc. (ELEV) Delisted | Mixed | +5,223 | -$2.8K | EDGAR |
| 2024-02-20 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-17 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-10 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-16 | Elevation Oncology, Inc. (ELEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-23 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2021-02-08 | BOLT | Grant (A) | — | $0 | EDGAR |